News | January 03, 2023
Blacksmith announces merger with Forge Therapeutics
To create leading company developing medicines targeting metalloenzymes
To create leading company developing medicines targeting metalloenzymes
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Quantori develops solutions on the Databricks Lakehouse Platform providing real-time insights
They also released the Operational Guidelines for Wellness activities at AB-HWCs
Tambe has been with Biocon since 1997 and has held diverse leadership and operational roles.
With this QIP placement, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 percent stake in the company by March 2023
Joint Drugs Controller (India) Dr PBN Prasad shared his views about working during harsh COVID-19 pandemic days
The expansion program includes investments in France and the U.S., adding an additional 23,000+ m² of manufacturing footprint.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Subscribe To Our Newsletter & Stay Updated
